| Literature DB >> 24582101 |
Abstract
Epidemics of obesity, diabetes, nonalcoholic fatty liver disease, and cognitive impairment/Alzheimer disease have emerged over the past 3 to 4 decades. These diseases share in common target-organ insulin resistance with a constellation of molecular and biochemical abnormalities that lead to organ/tissue degeneration over time. This article discusses the fundamental links among these diseases and how peripheral organ insulin resistance diseases contribute to cognitive impairment and neurodegeneration. A future role of endocrinologists and diabetologists could be to provide integrative diagnostic and treatment approaches for this collection of diseases that seem to share pathophysiological and pathogenetic bases.Entities:
Keywords: Alzheimer disease; Cognitive impairment; Diabetes; Insulin resistance; Insulin sensitizers; Neurodegeneration; Obesity
Mesh:
Year: 2013 PMID: 24582101 PMCID: PMC4978517 DOI: 10.1016/j.ecl.2013.09.006
Source DB: PubMed Journal: Endocrinol Metab Clin North Am ISSN: 0889-8529 Impact factor: 4.741